Answers are grounded in this paper and cite their sources.
In 2020, coronavirus disease 2019 (COVID-19) was one of the main causes of morbidity and mortality worldwide. During the pandemic, research focused on identifying risk factors that are associated with serious illness and biochemical markers that predict mortality. This study aims to determine if acute myocardial injury is an independent factor of poor prognosis in severe COVID-19 disease by measuring high-sensitivity troponin I. A retrospective, observational, analytical and cross-sectional case-control clinical study was carried out including patients with COVID-19, which were divided into two groups: those who presented troponin I values of high sensitivity within normal parameters and patients with seric values above the 99th percentile (>25ng/l). Variables studied were sociodemographic, clinical and laboratory data recorded at hospital admission. Parametric and non-parametric statistical tests were used to compare both groups and the OR of troponin I was calculated. A total of 285 patients were included, of which 225 were recruited into the control group and 60 in the problem group. We determined that those patients with high levels of troponin I have a 5 time greater risk of dying during their hospital stay, so troponin I can be used as an independent predictor of mortality in patients with SARS-CoV-2 infection.
No takes yet. Share an insight, caveat, or question.
García et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: